Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit CBP–NF-κB interaction in activated microglia
- 11 October 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 297 (5), 1181-1185
- https://doi.org/10.1016/s0006-291x(02)02305-7
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide inhibit chemokine production in activated microgliaGlia, 2002
- Chromium(VI) Inhibits the Transcriptional Activity of Nuclear Factor-κB by Decreasing the Interaction of p65 with cAMP-responsive Element-binding Protein-binding ProteinPublished by Elsevier ,1999
- VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNγ synthesis by T cellsJournal of Neuroimmunology, 1999
- Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Tumor Necrosis Factor α Transcriptional Activation by Regulating Nuclear Factor-kB and cAMP Response Element-binding Protein/c-JunPublished by Elsevier ,1998
- Phosphorylation of NF-κB p65 by PKA Stimulates Transcriptional Activity by Promoting a Novel Bivalent Interaction with the Coactivator CBP/p300Molecular Cell, 1998
- The Transcriptional Activity of NF-κB Is Regulated by the IκB-Associated PKAc Subunit through a Cyclic AMP–Independent MechanismCell, 1997
- Transcriptional control: Versatile molecular glueCurrent Biology, 1996
- A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear ReceptorsCell, 1996
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Nuclear protein CBP is a coactivator for the transcription factor CREBNature, 1994